BERLIN (Reuters) – German opposition leader Friedrich Merz, tipped to become chancellor in next month’s election, said on Tuesday U.S. President Donald
(Reuters) – Porsche confirmed its earnings outlook for 2024 of a 14-15% profit margin in a call with investors on Tuesday and
By Sinead Cruise and Lawrence White DAVOS, Switzerland (Reuters) – JPMorgan Chase & Co (NYSE:JPM) bankers worked through the night in a “war
Investing.com — Match Group Inc (NASDAQ:MTCH).’s outlook has been revised from positive to stable due to weak operating performance of
Investing.com — Social media platform Rumble has announced that it has achieved a new all-time high for average concurrent creator livestreams on
HOUSTON (Reuters) – U.S. President Donald Trump has ended the moratorium on new liquefied natural gas export permits imposed by his predecessor
NEW YORK (Reuters) – A federal judge on Tuesday rejected Citigroup (NYSE:C)’s bid to dismiss a lawsuit by New York
Investing.com — SoundHound AI , Inc. (NASDAQ:SOUN) stock surged 15% as the company announced a partnership with Rekor Systems, Inc. (NASDAQ:REKR)
Investing.com — The U.S. restaurant industry is poised for modest growth in 2025, with sales projected to rise nearly 5%, up from
Investing.com — David Einhorn of Greenlight Capital recently discussed the current state of the cryptocurrency market, pointing out, “[w]e have reached the
Former President Joe Biden doled out a flurry of pardons during his final days in office, but he did not issue a
By Jonathan Stempel (Reuters) -Harvard University will provide additional protections for Jewish students under a settlement announced on Tuesday that resolves two lawsuits
By Stine Jacobsen COPENHAGEN (Reuters) – European wind shares fell on Tuesday after U.S. President Donald Trump axed support for new offshore wind
By Carey L Biron WASHINGTON( Thomson Reuters (NYSE:TRI) Foundation) -The devastation of the Los Angeles wildfires has resonated far beyond Southern California,
Investing.com — President Trump is preparing to disclose a significant private sector commitment to the development of artificial intelligence infrastructure in the
Investing.com — Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug Administration (FDA)
